The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have ...

Ousted FDA biologics and vaccine chief Peter Marks was asked to provide non-existent data on the risk from measles vaccines, ...

On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...

GSK and Pfiz­er have set­tled a law­suit al­leg­ing Pfiz­er’s RSV shot Abrys­vo in­fringed GSK’s patents. A Pfiz­er ...

Federal Trade Commission Chairman Andrew Ferguson said he wants to bring back the agency’s case against pharmacy benefit ...

At least 2,000 of the 10,000 HHS employees let go this week will be reinstated because of “mistakes,” Robert F. Kennedy Jr.

NIH over grant disruptions amid Trump admin cuts, citing canceled grants on DEI/transgender/vaccine topics & mass layoffs of ...

Eli Lilly licenses Sangamo's BBB-penetrating AAV capsid for CNS disease with $18M upfront; deal includes option for 4 more ...

The Cambridge, MA-based biotech is letting go of about 70 employees, a spokesperson confirmed to Endpoints News on Friday ...

Shanghai's RiboX Therapeutics begins first-ever circular RNA clinical trial, targeting dry mouth in cancer patients. Company ...

Singapore VC firm Vickers Venture Partners files for $180M IPO for second SPAC, Vickers Vantage Corp. II, following 2022 ...

Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate ...